Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 11273 - 11280 of 12029 results
California's AG Puts Mobile Apps on Notice
November 6, 2012| Blog| Viewpoint
Wage and Hour Considerations and Inclement Weather: In the Wake of Hurricane Sandy
November 6, 2012| Blog| Viewpoint
New York Employers May Not Seek to Prevent Their Employees From Voting or Attempt to Improperly Influence Their Votes
November 5, 2012| Blog| Viewpoint
Commercial Landlords Seek Share of Tenants' Online Sales
November 4, 2012| News
2013 Medicare Physician Fee Schedule: Issues of Interest to Independent Laboratories
November 2, 2012| Blog| Viewpoint
The FTC Fires Back Against Wyndham
November 2, 2012| Blog| Viewpoint
Google and Rosetta Stone Settle AdWords Trademark Infringement Suit
October 31, 2012| Blog| Viewpoint
Section 409A Document Correction Relief: Take the Final Bite of the Apple before December 31st
October 30, 2012| Blog| Viewpoint
News & Press Releases
San Francisco Business Times featured Mintz’s new office lease in San Francisco at 525 Market St. The firm will be increasing its footprint in downtown by 50% to 29,000 square feet on a whole single floor with the new space.
Mintz advised the underwriters in connection with a $230 million public offering by Cogent Biosciences, Inc. of 25,555,556 shares of common stock, which includes 3,333,333 shares issued pursuant to the exercise in full by the underwriters of their option to purchase additional shares of common stock, offered at a public offering price of $9.00 per share. The aggregate gross proceeds to Cogent from this offering were approximately $230 million, including proceeds from the exercise in full by the underwriters of the option to purchase additional shares, before deducting underwriting discounts and commissions and other offering expenses.
Mintz advised the underwriters in connection with a $200 million public offering by Soleno Therapeutics, Inc. of 2,352,941 shares of its common stock at a price to the public of $85.00 per share. The gross proceeds to Soleno from the offering were approximately $200 million before deducting underwriting discounts and commissions and other offering expenses. In addition, Soleno granted the underwriters a 30-day option to purchase up to an additional 352,941 shares of its common stock at the public offering price.
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|